Sanofi Genzyme: HCP Unbranded Oncology
Role: CD/Copywriter

A new generation of SERDs (Selective Estrogen Receptor Degraders) with better bioavailability is available, designed to block estrogen around the clock in ER+/HER2- advanced breast cancer. This campaign draws on retro neon signage to bring that nonstop protection to life.